Authorization No. 214330-3W
September 8, 2016
Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised his authority to temporarily suspend Dr. Anand Rabindranauth Persaudís authorization to treat injured workers within the New York State workersí compensation system effective September 8, 2016. Dr. Persaud's last known business address is 173-25 Jamaica Avenue, Jamaica, New York 11432.
The Chairís designeeís investigation has revealed that the New York State Department of Health, State Board for Professional Medical Conduct (BPMC) has issued Order # 16-193, wherein Dr. Persaud agreed not to contest the allegations in the four specifications, including that he inappropriately prescribed controlled substances, including but not limited to oxycodone, without performing an appropriate medical evaluation or maintaining appropriate medical documentation, that he was convicted of Criminal Sale of A Prescription for a Controlled Substance, a Class C felony, in violation of N.Y. Penal Law Sec. 220.65 for knowingly selling a prescription for Oxycodone to a patient, and that he was convicted of Criminal Tax Fraud in the Fourth Degree, a Class E felony, in violation of N.Y. Tax Code Sec. 1803 for knowingly submitting a materially false or fraudulent tax return, resulting in the surrender of his license to practice medicine in the state of New York.
Therefore, the Chair believes that Dr. Persaud may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.
Dr. Persaud is prohibited from rendering treatment and care to injured workers while his authorization is temporarily suspended. Reports submitted by Dr. Persaud for services rendered prior to September 8, 2016, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Persaud for services rendered prior to September 8, 2016 should not be denied due to the suspension of his authorization.
This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Directorís Office at 1 (800) 781-2362.
Kenneth J. Munnelly